dc.contributor.author | Mangahas, Theresa | eng |
dc.contributor.author | Huang, Grace | eng |
dc.contributor.author | Neher, Jon O. | eng |
dc.contributor.author | Safranek, Sarah | eng |
dc.date.issued | 2013 | eng |
dc.description.abstract | Metformin therapy reduces the risk of developing diabetes for adults with one or more risk factors for at least 5 years (strength of recommendation [SOR]: A, consistent meta-analyses) and perhaps as long as 10 years (SOR: B, randomized clinical trial [RCT]). Lifestyle modification with diet and exercise is approximately twice as effective as metformin for preventing diabetes, especially in older patients (SOR: B, RCTs). | eng |
dc.identifier.uri | http://hdl.handle.net/10355/37330 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2013 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | Journal of family practice, 62, no. 08 (August 2013): 436-437. | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | diabetes prevention | eng |
dc.subject | lifestyle modification | eng |
dc.subject.lcsh | Non-insulin-dependent diabetes | eng |
dc.subject.lcsh | Medicine, Preventive | eng |
dc.subject.lcsh | Metformin | eng |
dc.title | Does metformin prevent diabetes in at-risk adults? | eng |
dc.type | Article | eng |